Full Text View
Tabular View
Study Results
Related Studies
Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
This study has been completed.
Study NCT00882557   Information provided by Cubist Pharmaceuticals

First Received on April 15, 2009.   Last Updated on September 16, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End-stage Renal Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency
More general conditions related to this trial
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
daptomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services